Payman Khales bought ITGR once, on Oct 30, 2025

Payman Khales is the President and Chief Executive Officer of Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO) serving cardiac rhythm management, neuromodulation, and cardio & vascular markets.( He assumed this role on October 24, 2025, succeeding Joseph Dziedzic, who retired after eight years and continues as an advisor until March 31, 2026; Khales also joined the company's Board of Directors.(

Khales joined Integer in 2018 as President of the Cardio & Vascular business, where he implemented a market- and customer-focused strategy that doubled sales in seven years, drove above-market growth, and improved profitability and service levels.( He later served as Chief Operating Officer, overseeing both business units and global operations.( Prior to Integer, he held senior leadership roles at CECO Environmental Corp., including President of the Environmental Technologies segment, and at Ingersoll Rand Company.( Khales holds an Executive MBA from Indiana University’s Kelley School of Business and a Bachelor of Science in Mechanical Engineering from École Polytechnique de Montréal.(

Written by Perplexity from public sources.